Literature DB >> 30219700

The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.

Jocelyn S Gandelman1, John Zic2, Anna K Dewan2, Stephanie J Lee3, Mary Flowers3, Corey Cutler4, Joseph Pidala5, Heidi Chen6, Madan H Jagasia7, Eric R Tkaczyk8.   

Abstract

Little is known about the anatomic distribution of cutaneous chronic graft-versus-host disease (cGVHD). Using data from the cGVHD Consortium Improving Outcomes Assessment Study, we describe the frequency and extent of erythema and superficial and deep sclerosis in 8 anatomic sites in patients with incident disease (ie, new cGVHD diagnosis within 3 months of study entry) receiving systemic therapy. Of 339 patients with incident disease, 182 (54%) had skin involvement. When an extremity was involved, the same type of disease was present contralaterally in 92% of cases, revealing a high level of symmetry. As anticipated, erythema was the most common incident feature; however, sclerotic skin involvement at the time of cGVHD diagnosis was more common than has been suggested by previous studies. Erythema occurred in 155 (85%) and sclerosis in 53 (29%) of the patients with skin involvement (46% and 16%, respectively, of the entire cohort of 339 incident cGVHD cases). Erythema was least common on the lower extremities (n = 71; 39% of patients with skin involvement). Moveable sclerosis was rare on the head, neck, and scalp (n = 4; 2%). Deep sclerosis did not occur in this region, and instead was most likely to occur on the upper extremities (n = 14; 8%) and lower extremities (n = 14; 8%). More than one-half of patients with erythema (n = 107; 58.7%) had diffuse involvement (4 or more of 8 sites involved), compared with less than one-third of those with sclerosis (n = 16; 30.2%).
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Anatomic distribution; Chronic graft-versus-host disease; Erythema; Fasciitis; Sclerosis; cGVHD

Mesh:

Year:  2018        PMID: 30219700      PMCID: PMC6546305          DOI: 10.1016/j.bbmt.2018.09.007

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  25 in total

1.  Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

Authors:  David A Jacobsohn; Brenda F Kurland; Joseph Pidala; Yoshihiro Inamoto; Xiaoyu Chai; Jeanne M Palmer; Sally Arai; Mukta Arora; Madan Jagasia; Corey Cutler; Daniel Weisdorf; Paul J Martin; Steven Z Pavletic; Georgia Vogelsang; Stephanie J Lee; Mary E D Flowers
Journal:  Blood       Date:  2012-07-06       Impact factor: 22.113

2.  NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.

Authors:  L M Curtis; L Grkovic; S A Mitchell; S M Steinberg; E W Cowen; M B Datiles; J Mays; C Bassim; G Joe; L E Comis; A Berger; D Avila; T Taylor; D Pulanic; K Cole; J Baruffaldi; D H Fowler; R E Gress; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2014-08-25       Impact factor: 5.483

3.  Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation.

Authors:  Mathilde Tardieu; Michel Rybojad; Régis Peffault de Latour; Marie Robin; Adèle de Masson; Aliénor Xhaard; Hélène Le Buanec; Nathalie Parquet; Flore Sicre de Fontbrune; Anne Bergeron; Catherine Scieux; Valérie Dessirier; Armand Bensussan; Martine Bagot; Gérard Socié; Jean-David Bouaziz
Journal:  Blood       Date:  2013-07-18       Impact factor: 22.113

4.  Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study.

Authors:  Joseph Pidala; Georgia Vogelsang; Paul Martin; Xiaoyu Chai; Barry Storer; Steven Pavletic; Daniel J Weisdorf; Madan Jagasia; Corey Cutler; Jeanne Palmer; David Jacobsohn; Sally Arai; Stephanie J Lee
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

5.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

6.  A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

Authors:  Sandra A Mitchell; David Jacobsohn; Kimberly E Thormann Powers; Paul A Carpenter; Mary E D Flowers; Edward W Cowen; Mark Schubert; Maria L Turner; Stephanie J Lee; Paul Martin; Michael R Bishop; Kristin Baird; Javier Bolaños-Meade; Kevin Boyd; Jane M Fall-Dickson; Lynn H Gerber; Jean-Pierre Guadagnini; Matin Imanguli; Michael C Krumlauf; Leslie Lawley; Li Li; Bryce B Reeve; Janine Austin Clayton; Georgia B Vogelsang; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-12       Impact factor: 5.742

7.  Characteristics of chronic GVHD after cord blood transplantation.

Authors:  L F Newell; M E D Flowers; T A Gooley; F Milano; P A Carpenter; P J Martin; C Delaney
Journal:  Bone Marrow Transplant       Date:  2013-04-15       Impact factor: 5.483

8.  Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients.

Authors:  Pablo F Peñas; María Jones-Caballero; Maximiliano Aragüés; Jesús Fernández-Herrera; Javier Fraga; Amaro García-Díez
Journal:  Arch Dermatol       Date:  2002-07

9.  A single-center pilot validation study of a new chronic GVHD skin scoring system.

Authors:  Hildegard T Greinix; David Pohlreich; Jacqueline Maalouf; Peter Soukup; Volker Supper; Peter Kalhs; Robert M Knobler
Journal:  Biol Blood Marrow Transplant       Date:  2007-04-23       Impact factor: 5.742

Review 10.  The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

Authors:  Kenneth R Cooke; Leo Luznik; Stefanie Sarantopoulos; Frances T Hakim; Madan Jagasia; Daniel H Fowler; Marcel R M van den Brink; John A Hansen; Robertson Parkman; David B Miklos; Paul J Martin; Sophie Paczesny; Georgia Vogelsang; Steven Pavletic; Jerome Ritz; Kirk R Schultz; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-03       Impact factor: 5.742

View more
  2 in total

Review 1.  Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review.

Authors:  Hadir Shakshouk; Eric R Tkaczyk; Edward W Cowen; Rokea A El-Azhary; Shahrukh K Hashmi; Saad J Kenderian; Julia S Lehman
Journal:  Transplant Cell Ther       Date:  2021-06-06

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report.

Authors:  Carrie L Kitko; Joseph Pidala; Hélène M Schoemans; Anita Lawitschka; Mary E Flowers; Edward W Cowen; Eric Tkaczyk; Nosha Farhadfar; Sandeep Jain; Philipp Steven; Zhonghui K Luo; Yoko Ogawa; Michael Stern; Greg A Yanik; Geoffrey D E Cuvelier; Guang-Shing Cheng; Shernan G Holtan; Kirk R Schultz; Paul J Martin; Stephanie J Lee; Steven Z Pavletic; Daniel Wolff; Sophie Paczesny; Bruce R Blazar; Stephanie Sarantopoulos; Gerard Socie; Hildegard Greinix; Corey Cutler
Journal:  Transplant Cell Ther       Date:  2021-04-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.